We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

How can we help you today?

EN
Contact Us
  • 01-783.png
Medical Device Reg. No. 20262400337 (Guangdong)

β-Amyloid 1-40 (Aβ1-40) Assay Kit

The Aβ42/Aβ40 ratio is a key indicator in the diagnosis of Alzheimer's disease (AD). By detecting blood levels of Aβ40 and Aβ42, it effectively reflects the deposition of amyloid-beta in the brain. The abnormal changes in Aβ42, combined with the relative stability of Aβ40, make the Aβ42/Aβ40 ratio an important biomarker for evaluating AD pathological progression. This ratio not only facilitates the early identification of AD risk but also enables the monitoring of disease progression and therapeutic efficacy, providing robust support for clinical decision-making.

Inquire Now

  • Complete Product Line

    Offers a comprehensive product series to fully meet clinical multi-marker diagnostic needs based on the “A+T+N” standard

  • Leading Performance

    Optimized with self-developed core raw materials, sensitivity reaches sub-pg level.

  • High Automation, Rapid Testing

    Integrated with a high-performance fully automated instrument platform, single-tube loading; first report in 20 min.

  • Stable and Fast Results

    Testing throughput up to 200 T/H, intra-batch CV ≤ 8%, inter-batch CV ≤ 15%

  • Economic Advantage

    The overall solution offers significant cost advantages, effectively reducing the operational burden on medical institutions.

image.png